Allow companies to test others' products, if they find serious problems then any fines resulting from a resulting FDA investigation are split between the govt and the company that found the issues. With generics there cannot be that much "This is a trade secret" since it is already in the open.
I am sure they would be falling over each other to cripple the competition.
Fire away.
I think one of the issues is that fines need to be huge, penalties painful, and decisions punishing to companies who get caught doing wrong.
"Accountability" is paraded around a lot these days when dressing up a commpany in buzzwords. Our employees are accountable. I'm accountable. You're accountable.
Starting sending CEOs and CXXs to jail, and it will stop.
Also, you'd get a lot of very zealous people applying for those jobs. Heck, you could probably quadruple the inspection teams just with people willing to take low salary and treat it like playing the lottery.
Doctors and regulators in the FDA who protect the public from these drugs / drug companies are heroes. Perhaps it's not just the whistle blowers who should be getting 1/3rd of the settlement, but another portion should be set aside for performance awards for key people who made the case.
Frankly though $500m wasn't enough. $5b would have properly shuttered this rotten steaming pile of a company.
It's currently having a comeback and showing huge promise for cancer treatment:
http://www.mayoclinic.org/diseases-conditions/cancer/in-dept...
You're right it's an effective (although very expensive) cancer treatment. At least a prescription now comes with a strict program to try to prevent exposing any fetuses. A far cry from a treatment for morning sickness. I can't get over the audacity of Gruenenthal (the German company who sold it). At least they finally got around to apologizing: http://www.bbc.com/news/health-19443910
http://faculty.haas.berkeley.edu/dalbo/Regulatory_Capture_Pu...
http://www.tobinproject.org/books-papers/preventing-capture